Latest news and research on all cancers and treatments, updated several times a week, plus 10,000-item data base of these
FDA expands use of Imbruvica to treat rare form of cancer ... macroglobulinemia, a rare form of cancer that begins in the body's immune system.
“TRAIL is a naturally occurring part of the body's immune system that kills cancer cells without toxicity to normal cells,” Dr. Uckun explained. “However ...
This genetic network was also present in other tumor types, including prostate, pancreatic and bladder cancer. This demonstrates that TTP is involved ...
... of breast cancer (43.4%), prostate cancer (21.2%), colorectal cancer (16.2%), uterine cancer (7.3%), melanoma (6.8%) and bladder cancer (5.2%).
And by the time they are, the cancer has progressed into the late stages, leading to ... It is also the first in Texas to be certified for pancreatic cancer.
“We are excited to receive two separate orphan drug designations for tarextumab for the treatment of pancreatic and small-cell lung cancer,” said Paul ...
OncoMed Pharma (OMED) Tarextumab for the Treatment of Pancreatic and Small Cell Lung ... -StreetInsider.comFDA Grants Orphan Drug Designations to OncoMed's Tarextumab for the Treatment of Pancreatic ... -MarketWatch
“In our hands, gemcitabine, docetaxel and capecitabine is the most active regimen in pancreatic cancer causing documented regression in the ...
By contrast, Lilly spent hundreds of millions of dollars on clinical trials to show that its drug Gemzar initially introduced to treat pancreatic cancer was ...
That is until you have cancer, and then the body's balance is out of whack. This is the case with pancreatic cancer. Researchers at the University of ...
Cancer News in Science Daily
A strong link between the most aggressive type of breast cancer and a gene that regulates the body's natural cellular recycling process, called autophagy, has been uncovered by researchers.
Two new fluorescent dyes attracted to cancer cells may help neurosurgeons more accurately localize and completely resect brain tumors, suggests a new study. Removing all visible areas of cancer (gross total resection) significantly improves survival after brain cancer surgery.
Scientists have discovered a 'hidden' mechanism which could explain why some cancer therapies which aim to block tumor blood vessel growth are failing cancer trials. The same mechanism could play the role in the bacterial or viral septic shock -- e.g. in Ebola fever -- by destabilizing the blood vessels.
Using whole genomic sequencing, scientists have for the first time demonstrated the profound effect that chronic hepatitis infection and inflammation can have on the genetic mutations found in tumors of the liver, potentially paving the way to a better understanding of the mechanisms through which these chronic infections can lead to cancer. Primary liver cancer is the third leading cause of cancer death worldwide, and recent studies have shown that particularly in Asia, infection with either hepatitis B or C is often associated with such cancers.
Tambahkan Komentar